Skip to content
Screener

Haemonetics HAE Apheresis — D&A

Other segment segments

MedSurg
$13.48M—

Similar metrics at other companies

Flexible Solutions International logo
FSID&A
$509.5K+9.5%
Taboola.com Ltd. logo
TBLAD&A
$10.77M-54.6%
Macerich logo
MACD&A
$86.22M-2.6%
TRN
TRNOD&A
$29.15M+4.0%
Zeta Global Holdings logo
ZETAD&A
$22.66M+30.2%
Circle Internet Group logo
CRCLD&A
$29.9M+110%

Other financials

Income statement

See full
Revenue$339.4M+5.6%
Gross profit$202.8M+5.5%
Operating income$57.5M+6.7%
Net income$33.0M-3.0%
EPS (diluted)$0.72+2.9%

Balance sheet

See full
Cash & equivalents$223.4M-23.7%
Total debt$1.2B-4.1%
Total equity$837.1M-5.1%
Total assets$2.4B-3.9%

Cash flow

See full
Operating cash flow$52.3M+201%
CapEx$7.9M+111%
Free cash flow$44.4M+226%

Valuation

See full
Market cap$3.8B+4.4%
Enterprise value$4.75B+3.9%
P/E25.3×-10.3×
P/S2.8×+0.1×

Profitability

See full
Gross margin59%+2.1pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin21.5%+7.5pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.4×0.0×
Current ratio3.1×+1.4×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.

The source filing: Haemonetics’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:09 AM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0000313143-26-000120
Line itemThree Months Ended / June 27, 2026June 28, 2025
Apheresis$13,631$13,912
MedSurg13,48014,846
Total depreciation and amortization (excluding impairment charges)$27,111$28,758

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Haemonetics's apheresis — D&A?
Haemonetics (HAE) reported apheresis — D&A of $13.63M in Q2 2026.
What does apheresis — D&A mean?
This metric reflects the non-cash expense allocated to the apheresis segment for the systematic reduction in the value of tangible and intangible assets over their useful lives. It provides insight into the capital intensity of the segment's operations and the ongoing investment required to maintain its technological infrastructure. Analyzing this expense helps in evaluating the segment's true operational cash flow and the efficiency of its asset base.

Ask your AI about Haemonetics's apheresis — d&a.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude